Use of conventional synthetic and biologic disease-modifying anti-rheumatic drugs in patients with rheumatic diseases contracting COVID-19: a single-center experience.

Autor: Migkos MP; Rheumatology Clinic, Department of Internal Medicine, Medical School, University of Ioannina, 45110, Ioannina, Greece., Kaltsonoudis E; Rheumatology Clinic, Department of Internal Medicine, Medical School, University of Ioannina, 45110, Ioannina, Greece., Pelechas E; Rheumatology Clinic, Department of Internal Medicine, Medical School, University of Ioannina, 45110, Ioannina, Greece., Drossou V; Rheumatology Clinic, Department of Internal Medicine, Medical School, University of Ioannina, 45110, Ioannina, Greece., Karagianni PG; Laboratory Medicine, Department of Microbiology, Medical School, University of Ioannina, 45110, Ioannina, Greece., Kavvadias A; Gastroenterology Clinic, Department of Internal Medicine, Medical School, University of Ioannina, 45110, Ioannina, Greece., Voulgari PV; Rheumatology Clinic, Department of Internal Medicine, Medical School, University of Ioannina, 45110, Ioannina, Greece., Drosos AA; Rheumatology Clinic, Department of Internal Medicine, Medical School, University of Ioannina, 45110, Ioannina, Greece. adrosos@uoi.gr.

Publikováno v: Rheumatology international [Rheumatol Int] 2021 May; Vol. 41 (5), pp. 903-909. Date of Electronic Publication: 2021 Mar 03.

Application of biological medicinal products and tyrosine kinase inhibitors in rheumatoid arthritis and COVID-19: A systematic review of scientific literature.

Autor: Parvova, Iva, Yordanov, Emanuil, Hristov, Emil, Petkova, Valentina

Publikováno v: Pharmacia (0428-0296); 2024, Vol. 71 Issue 1, p1-8, 8p

COVID-19 in patients with gout on colchicine.

Autor: Pelechas, Eleftherios, Drossou, Vassiliki, Voulgari, Paraskevi V., Drosos, Alexandros A.

Publikováno v: Rheumatology International; Aug2021, Vol. 41 Issue 8, p1503-1507, 5p